Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Philippe GaudardMarine SaourDavid MorquinHélène DavidJacob ElietMaxime VillietJean-Pierre DauresPascal ColsonPublished in: BMC infectious diseases (2019)
Daptomycin appears to be safer than vancomycin in terms of AKI risk in ICU patients treated for cardiovascular procedure-related infection. Daptomycin could be considered as a first line treatment to prevent AKI in high-risk patients.
Keyphrases
- acute kidney injury
- methicillin resistant staphylococcus aureus
- cardiac surgery
- end stage renal disease
- staphylococcus aureus
- ejection fraction
- newly diagnosed
- chronic kidney disease
- intensive care unit
- peritoneal dialysis
- prognostic factors
- minimally invasive
- mechanical ventilation
- acute respiratory distress syndrome
- drug induced
- smoking cessation
- data analysis